Platelets and vascular integrity: How platelets prevent bleeding in inflammation

Blood

Volumn 131, Issue 3, 2018, Pages 277-288

  Ho Tin Noé, Benoit ^a   Boulaftali, Yacine ^a   Camerer, Eric ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE RECEPTOR;

BLEEDING; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CELL INTERACTION; CELL TRANSPORT; ENDOTHELIUM CELL; HEMOSTASIS; INFECTION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTE FUNCTION; VASCULARIZATION; ANIMAL; BLOOD VESSEL; HUMAN; PATHOLOGY; THROMBOCYTE AGGREGATION; ULTRASTRUCTURE;

ANIMALS; BLOOD PLATELETS; BLOOD VESSELS; ENDOTHELIAL CELLS; HEMORRHAGE; HUMANS; INFLAMMATION; PLATELET AGGREGATION;

EID: 85040836584     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2017-06-742676     Document Type: Review

References (104)

1. Murakami M, Simons M. Regulation of vascular integrity. J Mol Med (Berl). 2009;87(6): 571-582
2. Petri B, Broermann A, Li H, et al. von Willebrand factor promotes leukocyte extravasation. Blood. 2010;116(22):4712-4719.
3. Ho-Tin-Noé B, Demers M, Wagner DD. How platelets safeguard vascular integrity. J Thromb Haemost. 2011;9(Suppl 1):56-65.
4. Cosentino F, Luscher TF. Maintenance of vascular integrity: role of nitric oxide and other bradykinin mediators. Eur Heart J. 1995;16(Suppl K):4-12.
5. Majno G, Palade GE. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol. 1961;11(3):571-605.
6. Cotran RS. The delayed and prolonged vascular leakage in inflammation. II. An electron microscopic study of the vascular response after thermal injury. Am J Pathol. 1965;46:589-620.
7. Hurley JV, Xeros N. Electron microscopic observations on the emigration of leucocytes. Aust J Exp Biol Med Sci. 1961;39: 609-623.
8. Marchesi VT. Some electron microscopic observations on interactions between leukocytes, platelets, and endothelial cells in acute inflammation. Ann N Y Acad Sci. 1964; 116(3):774-788.
9. Marchesi VT, Florey HW. Electron micro-graphic observations on the emigration of leucocytes. Q J Exp Physiol Cogn Med Sci. 1960;45:343-348.
10. Jiang P, Ren YL, Lan Y, et al. Phagocytosis of platelets enhances endothelial cell survival under serum deprivation. Exp Biol Med (Maywood). 2015;240(7):876-883.
11. Faille D, Combes V, Mitchell AJ, et al. Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J. 2009;23(10): 3449-3458.
12. Faille D, El-Assaad F, Mitchell AJ, et al. Endocytosis and intracellular processing of platelet microparticles by brain endothelial cells. J Cell Mol Med. 2012;16(8):1731-1738.
13. Ma R, Xie R, Yu C, et al. Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis. Sci Rep. 2017;7(1):4978.
14. Daito J, Harada Y, Dai P, et al. Neutrophil phagocytosis of platelets in the early phase of 2,4,6-trinitro-1-chlorobenzene (TNCB)induced dermatitis in mice. Acta Histochem Cytochem. 2014;47(2):67-74.
15. Goerge T, Ho-Tin-Noe B, Carbo C, et al. Inflammation induces hemorrhage in thrombocytopenia. Blood. 2008;111(10): 4958-4964.
16. Iannacone M, Sitia G, Isogawa M, et al. Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus. Proc Natl Acad Sci USA. 2008;105(2):629-634.
17. Loria GD, Romagnoli PA, Moseley NB, Rucavado A, Altman JD. Platelets support a protective immune response to LCMV by preventing splenic necrosis. Blood. 2013; 121(6):940-950.
18. Schnell FJ, Sundholm S, Crumley S, Iversen PL, Mourich DV. Lymphocytic choriomeningitis virus infection in FVB mouse produces hemorrhagic disease. PLoS Pathog. 2012; 8(12):e1003073.
19. de Stoppelaar SF, van’t Veer C, Claushuis TA, Albersen BJ, Roelofs JJ, van der Poll T. Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice. Blood. 2014;124(25):3781-3790.
20. Hillgruber C, Pöppelmann B, Weishaupt C, et al. Blocking neutrophil diapedesis prevents hemorrhage during thrombocytopenia. J Exp Med. 2015;212(8):1255-1266.
21. Gazit SL, Mariko B, Thérond P, et al. Platelet and Erythrocyte Sources of S1P Are Redundant for Vascular Development and Homeostasis, but Both Rendered Essential After Plasma S1P Depletion in Anaphylactic Shock. Circ Res. 2016;119(8):e110-e126.
22. Demers M, Ho-Tin-Noé B, Schatzberg D, Yang JJ, Wagner DD. Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice. Cancer Res. 2011;71(5): 1540-1549.
23. Ho-Tin-Noé B, Goerge T, Cifuni SM, Duerschmied D, Wagner DD. Platelet granule secretion continuously prevents intra-tumor hemorrhage. Cancer Res. 2008;68(16): 6851-6858.
24. Ho-Tin-Noé B, Goerge T, Wagner DD. Platelets: guardians of tumor vasculature. Cancer Res. 2009;69(14):5623-5626.
25. Hirahashi J, Hishikawa K, Kaname S, et al. Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury. Circulation. 2009;120(13):1255-1265.
26. Carbo C, del Conde I, Duerschmied D. Petechial bleeding after sunburn in a patient with mild thrombocytopenia. Am J Hematol. 2009;84(8):523.
27. Faloon WW, Greene RW, Lozner EL. The hemostatic defect in thrombocytopenia as studied by the use of ACTH and cortisone. Am J Med. 1952;13(1):12-20.
28. Kitchens CS, Pendergast JF. Human thrombocytopenia is associated with structural abnormalities of the endothelium that are ameliorated by glucocorticosteroid administration. Blood. 1986;67(1):203-206.
29. Friedmann AM, Sengul H, Lehmann H, Schwartz C, Goodman S. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. Transfus Med Rev. 2002;16(1): 34-45.
30. Lee JH, Park KY, Shin JH, et al. Symptomatic hemorrhagic transformation and its predictors in acute ischemic stroke with atrial fibrillation. Eur Neurol. 2010;64(4):193-200.
31. Assinger A. Platelets and infection - an emerging role of platelets in viral infection. Front Immunol. 2014;5:649.
32. Boulaftali Y, Hess PR, Getz TM, et al. Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest. 2013;123(2): 908-916.
33. Deppermann C, Kraft P, Volz J, et al. Platelet secretion is crucial to prevent bleeding in the ischemic brain but not in the inflamed skin or lung in mice. Blood. 2017;129(12): 1702-1706.
34. Gros A, Syvannarath V, Lamrani L, et al. Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex-mediated inflammation in mice. Blood. 2015;126(8):1017-1026.
35. Camerer E, Cornelissen I, Kataoka H, Duong DN, Zheng YW, Coughlin SR. Roles of protease-activated receptors in a mouse model of endotoxemia. Blood. 2006;107(10): 3912-3921.
36. Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science. 2010;327(5965):580-583.
37. Cloutier N, Paré A, Farndale RW, et al. Platelets can enhance vascular permeability. Blood. 2012;120(6):1334-1343.
38. Hara T, Shimizu K, Ogawa F, et al. Platelets control leukocyte recruitment in a murine model of cutaneous arthus reaction. Am J Pathol. 2010;176(1):259-269.
39. Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest. 2006;116(12):3211-3219.
40. Grommes J, Alard JE, Drechsler M, et al. Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury. Am J Respir Crit Care Med. 2012;185(6):628-636.
41. Coller BS, Shattil SJ. The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood. 2008;112(8):3011-3025.
42. Nurden AT, Fiore M, Nurden P, Pillois X. Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models. Blood. 2011;118(23):5996-6005.
43. Ho-Tin-Noé B, Carbo C, Demers M, Cifuni SM, Goerge T, Wagner DD. Innate immune cells induce hemorrhage in tumors during thrombocytopenia. Am J Pathol. 2009; 175(4):1699-1708.
44. Herzog BH, Fu J, Wilson SJ, et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature. 2013;502(7469):105-109.
45. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res. 2006;99(12):1293-1304.
46. Woulfe DS. Platelet G protein-coupled receptors in hemostasis and thrombosis. J Thromb Haemost. 2005;3(10):2193-2200.
47. Bergmeier W, Boulaftali Y. Adoptive transfer method to study platelet function in mouse models of disease. Thromb Res. 2014; 133(Suppl 1):S3-S5.
48. Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation. 2007; 115(17):2323-2330.
49. Desilles JP, Loyau S, Syvannarath V, et al. Alteplase Reduces Downstream Microvas-cular Thrombosis and Improves the Benefit of Large Artery Recanalization in Stroke. Stroke. 2015;46(11):3241-3248.
50. Desilles JP, Syvannarath V, Ollivier V, et al. Exacerbation of Thromboinflammation by Hyperglycemia Precipitates Cerebral Infarct Growth and Hemorrhagic Transformation. Stroke. 2017;48(7):1932-1940.
51. Luo S, Zhuang M, Zeng W, Tao J. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta-analysis of 19 Studies. J Am Heart Assoc. 2016;5(5):5.
52. Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, De Keyser J, Luijckx GJ. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke. Arch Neurol. 2008;65(5):607-611.
53. Gardiner EE, Andrews RK. Structure and function of platelet receptors initiating blood clotting. Adv Exp Med Biol. 2014;844: 263-275.
54. De Meyer SF, Schwarz T, Schatzberg D, Wagner DD. Platelet glycoprotein Ibalpha is an important mediator of ischemic stroke in mice. Exp Transl Stroke Med. 2011;3:9. 2011.
55. Zhao BQ, Chauhan AK, Canault M, et al. von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. Blood. 2009;114(15): 3329-3334.
56. De Meyer SF, Stoll G, Wagner DD, Kleinschnitz C. von Willebrand factor: an emerging target in stroke therapy. Stroke. 2012;43(2):599-606.
57. Bender M, May F, Lorenz V, et al. Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice. Arterioscler Thromb Vasc Biol. 2013;33(5):926-934.
58. Watson SP, Herbert JM, Pollitt AY. GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost. 2010;8(7):1456-1467.
59. Manne BK, Badolia R, Dangelmaier C, et al. istinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets. J Biol Chem. 2015; 290(18):11557-11568.
60. Spalton JC, Mori J, Pollitt AY, Hughes CE, Eble JA, Watson SP. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets. J Thromb Haemost. 2009;7(7): 1192-1199.
61. Séverin S, Pollitt AY, Navarro-Nuñez L, et al. Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling. J Biol Chem. 2011;286(6):4107-4116.
62. Abtahian F, Guerriero A, Sebzda E, et al. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science. 2003;299(5604):247-251.
63. Lax S, Rayes J, Wichaiyo S, et al. Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse. Am J Physiol Lung Cell Mol Physiol. 2017;313(6):L1016-L1029.
64. Demers M, Wagner DD. Targeting platelet function to improve drug delivery. OncoImmunology. 2012;1(1):100-102.
65. Majno G, Palade GE, Schoefl GI. Studies on inflammation. II. The site of action of histamine and serotonin along the vascular tree: a topographic study. J Biophys Biochem Cytol. 1961;11(3):607-626.
66. Ryan GB, Majno G. Acute inflammation. A review. Am J Pathol. 1977;86(1):183-276.
67. Cochrane CG, Weigle WO, Dixon FJ. The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vascu-litis. J Exp Med. 1959;110(3):481-494.
68. Cochrane CG, Aikin BS. Polymorphonuclear leukocytes in immunologic reactions. The destruction of vascular basement membrane in vivo and in vitro. J Exp Med. 1966;124(4): 733-752.
69. Nourshargh S, Alon R. Leukocyte migration into inflamed tissues. Immunity. 2014;41(5): 694-707.
70. Voisin MB, Woodfin A, Nourshargh S. Monocytes and neutrophils exhibit both distinct and common mechanisms in penetrating the vascular basement membrane in vivo. Arterioscler Thromb Vasc Biol. 2009; 29(8):1193-1199.
71. Hurley JV. Acute inflammation: the effect of concurrent leucocytic emigration and increased permeability on particle retention by the vascular wall. Br J Exp Pathol. 1964;45: 627-633.
72. Wessel F, Winderlich M, Holm M, et al. Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin. Nat Immunol. 2014;15(3):223-230.
73. Hurley JV. An electron microscopic study of leucocytic emigration and vascular permeability in rat skin. Aust J Exp Biol Med Sci. 1963;41(2):171-186.
74. Gros A, Ollivier V, Ho-Tin-Noé B. Platelets in inflammation: regulation of leukocyte activities and vascular repair. Front Immunol. 2015;5:678.
75. Kirton CM, Nash GB. Activated platelets adherent to an intact endothelial cell monolayer bind flowing neutrophils and enable them to transfer to the endothelial surface. J Lab Clin Med. 2000;136(4): 303-313.
76. Jandrot-Perrus M, Busfield S, Lagrue AH, et al. Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin super-family. Blood. 2000;96(5):1798-1807.
77. Sreeramkumar V, Adrover JM, Ballesteros I, et al. Neutrophils scan for activated platelets to initiate inflammation. Science. 2014; 346(6214):1234-1238.
78. Barnes MJ, MacIntyre DE. Platelet-reactivity of isolated constituents of the blood vessel wall. Haemostasis. 1979;8(3-5):158-170.
79. Ozaki Y, Suzuki-Inoue K, Inoue O. Novel interactions in platelet biology: CLEC-2/ podoplanin and laminin/GPVI. J Thromb Haemost. 2009;7(Suppl 1):191-194.
80. Schaff M, Tang C, Maurer E, et al. Integrin a6b1 is the main receptor for vascular lam-inins and plays a role in platelet adhesion, activation, and arterial thrombosis. Circulation. 2013;128(5):541-552.
81. Inoue O, Suzuki-Inoue K, McCarty OJ, et al. Laminin stimulates spreading of platelets through integrin alpha6beta1-dependent activation of GPVI. Blood. 2006;107(4): 1405-1412.
82. Alshehri OM, Hughes CE, Montague S, et al. Fibrin activates GPVI in human and mouse platelets. Blood. 2015;126(13):1601-1608.
83. Mammadova-Bach E, Ollivier V, Loyau S, et al. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation. Blood. 2015;126(5):683-691.
84. Schulz C, von Brühl ML, Barocke V, et al. EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall. J Thromb Haemost. 2011;9(5): 1007-1019.
85. Seizer P, Borst O, Langer HF, et al. EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction. Thromb Haemost. 2009;101(4):682-686.
86. Yurchenko V, O’Connor M, Dai WW, et al. CD147 is a signaling receptor for cyclophilin B. Biochem Biophys Res Commun. 2001;288(4): 786-788.
87. Wang CH, Dai JY, Wang L, et al. Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes. J Cell Mol Med. 2011;15(4):850-860.
88. Navarro-Núñez L, Langan SA, Nash GB, Watson SP. The physiological and patho-physiological roles of platelet CLEC-2. Thromb Haemost. 2013;109(6):991-998.
89. Hitchcock JR, Cook CN, Bobat S, et al. Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets. J Clin Invest. 2015;125(12):4429-4446.
90. Peduto L, Dulauroy S, Lochner M, et al. Inflammation recapitulates the ontogeny of lymphoid stromal cells. J Immunol. 2009; 182(9):5789-5799.
91. Payne H, Ponomaryov T, Watson SP, Brill A. Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis. Blood. 2017;129(14):2013-2020.
92. Lee RH, Piatt R, Conley PB, Bergmeier W. Effects of ibrutinib treatment on murine platelet function during inflammation and i primary hemostasis. Haematologica. 2017; 102(3):e89-e92.
93. Hughan SC, Hughes CE, McCarty OJ, et a GPVI potentiation of platelet activation by thrombin and adhesion molecules independent of Src kinases and Syk. Arterioscler Thromb Vasc Biol. 2007;27(2): 422-429.
94. Haining EJ, Cherpokova D, Wolf K, et al. CLEC-2 contributes to hemostasis independently of classical hemITAM signalin in mice. Blood. 2017;130(20):2224-2228.
95. Drummond AH, Gordon JL. Proceedings: Kinetics of the platelet release reaction induced by collagen. Br J Pharmacol. 1974; 52(1):130P.
96. Ollivier V, Syvannarath V, Gros A, et al. Collagen can selectively trigger a platelet secretory phenotype via glycoprotein VI. PLoS One. 2014;9(8):e104712.
97. Camerer E, Regard JB, Cornelissen I, et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest. 2009;119(7):1871-1879.
98. Brandt E, Ludwig A, Petersen F, Flad HD. Platelet-derived CXC chemokines: old players in new games. Immunol Rev. 2000;177(1): 204-216.
99. Deppermann C, Nurden P, Nurden AT, Nieswandt B, Stegner D. The Nbeal2(-/-) mouse as a model for the gray platelet syndrome. Rare Dis. 2013;1(1): e26561.
100. Stegner D, Deppermann C, Kraft P, et al. Munc13-4-mediated secretion is essential for infarct progression but not intracranial hemostasis in acute stroke. J Thromb Haemost. 2013;11(7):1430-1433.
101. Mackman N. The role of tissue factor and factor VIIa in hemostasis. Anesth Analg. 2009;108(5):1447-1452.
102. David T, Kim YC, Ely LK, et al. Factor XIa-specific IgG and a reversal agent to probe factor XI function in thrombosis and hemostasis. Sci Transl Med. 2016;8(353):353ra112.
103. Renné T, Schmaier AH, Nickel KF, Blombäck M, Maas C. In vivo roles of factor XII. Blood. 2012;120(22):4296-4303.
104. Nieswandt B. How do platelets prevent bleeding? Blood. 2008;111(10):4835.